Amid NIH funding delays, clawbacks and uncertainty, a scientist at Harvard who studies breast cancer has lost one third of her lab employees and wonders if she can continue her research experiments.
Copyright 2025 NPR
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations